Dry eyes: Etiology and management

Current Opinion in Ophthalmology

Volumn 19, Issue 4, 2008, Pages 287-291

  Latkany, Robert ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Dry eye; Dry eyes; Dysfunctional tear syndrome; Ocular surface

Indexed keywords

ARTIFICIAL TEAR; BEVACIZUMAB; BROMFENAC; CYCLOSPORIN; DICLOFENAC; DOXYCYCLINE; EPINASTINE; FLUOROMETHOLONE; HORMONE; KETOROLAC; LORATADINE; NEPAFENAC; OLOPATADINE; ANTIINFLAMMATORY AGENT; EYE DROPS; IMMUNOSUPPRESSIVE AGENT;

ABSENCE OF SIDE EFFECTS; BLURRED VISION; CLINICAL EVALUATION; CONJUNCTIVITIS; CONTACT LENS; CORNEA NEOVASCULARIZATION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRY EYE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NOMENCLATURE; OPTICAL INSTRUMENTATION; PHOTOREFRACTIVE KERATECTOMY; PRIORITY JOURNAL; PUNCTAL PLUG; REVIEW; SYMPTOM; TOPICAL TREATMENT; VISION; ANIMAL; CHEMISTRY; HOSPITALIZATION; LACRIMAL FLUID; OSMOLARITY; SECRETION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DRY EYE SYNDROMES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OPHTHALMIC SOLUTIONS; OSMOLAR CONCENTRATION; SEVERITY OF ILLNESS INDEX; TEARS;

EID: 49849093565     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3283023d4c     Document Type: Review

References (45)

1. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf 2007; 5:75-93.
2. Begley CG, Chalmers RI, Aberz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci 2003; 44:4753-4761.
3. Adatia FA, Michaell-Cohen A, Naor J, et al. Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjogren's Syndrome. Can J Ophthalmol 2004; 39:767-771.
4. Vitale S, Goodman LA, Reed GE, Smith JA. Comparison of the NEI-VFQ and OSDI Questionnaires in patients with Sjogren's syndrome-related dry eye. Health Qual Outcomes 2004; 1:2-44.
5. Rieger G. The importance of the precorneal tear film for the quality of optical imaging. Br J Ophthalmol 1992; 76:157-158.
6. Liu Z, Pflugfelder SC. Corneal surface irregularity and the effect of artificial tears in aqueous tear deficiency. Ophthalmology 1999; 106:936-943.
7. Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol 2002; 133:181-186.
8. Holly F, Lemp MA. Formation and rupture of the tear film. Exp Eye Res 1973; 15:515-525.
9. Bron AJ. Diagnosis of dry eye. Surv Ophthalmol 2001; 45 (Suppl 2):5221-5226.
10. Goto T, Zheng X, Klyce SD, et al. A new method for tear film stability using videokeratography. Am J Ophthalmol 2003; 135:607-612.
11. Farris RL, Stuchell RN, Mandel ID. Tear osmolarity variation in the dry eye. Trans Am Ophthalmol Soc 1986; 84:250-268.
12. Gilbard JP. Human tear film electrolyte concentrations in health and dry eye disease. Int Ophthalmol Clin 1994; 34:27-36.
13. Murube J. Tear Osmolarity. Ocul Surf 2006; 1:62-73.
14. Tomlinson A, Khanal S, Ramaesh K, et al. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 2006; 47:4309-4315.
15. Pflugfelder SC, Jones d, Ji Z, et al. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999; 19:201-211.
16. Tsubota K, FujiharaT, Saito K,TakeuchiT. Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica 1999; 213:16-19.
17. Lemp MA. Report of the National Eye Insititute/Industry Workshop on clinical Trials in Dry Eye. CLAO J 1995; 21:221-232.
18. Uchiyama E, Aronowicz JD, Butovich IA, McCulley JP. Pattern of vital staining and its correlation with aqueous tear deficiency and meibomian gland dropout. Eye Contact Lens 2007; 33:177-179.
19. Erdogan-Poyraz C, Mocan MC, Irkec M, Orhan M. Delayed tear clearance in patients with conjunctivochalsis is associated with punctal occlusion. Cornea 2007; 26:290-293.
20. Serin D, Karshoglu S, Kiyan A, Alagoz G. A simple approach to the repeatability of the schirmer test without anesthesia. Eyes open or closed? Cornea 2007; 26:903-906.
21. Uchida A, Chino M,Goto E, et al. Noninvasive interference tear meniscometry in dry eye patients with Sjogren syndrome. Am J Ophthalmol 2007; 144:232-237.
22. Borchman D, Foulks GN, Yappert MC, et al. Spectroscopic evaluation of human tear lipids 2007. Chem Phys Lipids 2007; 147:87-102.
23. Esquenazi S, He J, Li N, et al. Comparitive in vivo high-resolution confocal microscopy of corneal epithelium, sub-basal nerves and stromal cells in mice with and without dry eye after photorefractive keratectomy. Clin Exp Ophthalmol 2007; 35:545-549.
24. Stonecipher KG, Green PT. Noncontact confocal microscopy of the tear film in unoperated eyes. J Ref Surg 2007; 23:417-419.
25. KaidoM, Dogru M, IshidaR, Tsubota K. Concept of functional visual acuity and its applications. Cornea 2007; 26 (suppl 1):S29-S34.
26. Montes-Mico R. Role of the tear film in the optical quality of the human eye. J Cat Ref Surg 2007; 33:1631-1635.
27. Versura P, Fresina M, Campos EC. Ocular surface changes over the menstrual cycle in women with and without dry eye. Gyn Endocrinol 2007; 23:385-390.
28. Huang T, Wang Y, Liu Z, et al. Investigation of tear film change after recovery from acute conjunctivitis. Cornea 2007; 26:778-781.
29. Chen W, Zhao K, Li X, Yoshitomi T. Keratoconjunctivitis sicca modifies epithelial stem cell proliferation kinetics in conjunctiva. Cornea 2007; 26:1101-1106.
30. Lekhanont K, Park CY, Smith JA, et al. Effects of topical anti-inflammatory agents in a botulinum toxin b-induced mouse model of keratoconjunctivitis sicca. J Ocul Pharm Thera 2007; 23:27-34.
31. Pflugfelder SC, De Paiva CS, Villareal AL, et al. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-B2 production. Cornea 2008; 27:64-69.
32. Lekhanont K, Park CY, Combs JC, et al. Effect of topical olopatadine and epinastine in the botulinum toxin B-induced mouse model of dry eye. J Ocul Pharm Thera 2007; 23:83-88.
33. Ousler GW, Workman A, Torkildsen GL. An open-label, investigator-masked, crossover study of the ocular drying effects of two antihistamines, topical epinastine and systemic loratadine, in adult volunteers with seasonal allergic conjunctivitis. Clin Therap 2007; 29:611-616.
34. Nezzar H, Chiambaretta F, Marceau G, et al. Molecular and metabolic retinoid pathways in the human ocular surface. Molecular Vision 2007; 13:1641-1650.
35. Hatchell DL, Sommer A. Detection of ocular surface abnormalities in experimental vitamin A deficiency. Arch Ophthalmol 1984; 102:1389-1393.
36. Erdurmus M, Totan Y. Subconjunctival bevacizumab for corneal neovascularization. Graefe's Arch Clin Exp Ophthalmol 2007; 245:1577-1579.
37. Uy HS, Chan PS, Ang RE. Topical bevacizumab and ocular surface neovascularization in patients with Stevens-Johnson syndrome. Cornea 2008; 27:70-73.
38. Jacobs DS, Rosenthal P. Boston scleral lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea 2007; 26:1195-1198.
39. Khalil MB, Latkany RA, Speaker MG, Yu G. Effect of punctal plugs in patients with low refractive errors considering refractive surgery. J Ref Surg 2007; 23:467-471.
40. Latkany R, Lock BG, Speaker M. Tear film normalization test: a new diagnostic for dry eyes. Cornea 2006; 25:1153-1157.
41. Roberts CW, Carniglia PE, Brazzo BG. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye. Cornea 2007; 26:805-809.
42. Horwath-Winter J, Thaci A, Gruber A, Boldin I. Long-term retention rates and complications of silicone punctal plugs in dry eye. Am J Ophthalmol 2007; 144:441-444.
43. Cordero-Coma M, Anzaar F, Sobrin L, Foster CS. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation. Ocul Immuno Inflammation 2007; 15:99-104.
44. Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf 2007; 5:163-178.
45. Wilson SE, Stulting RD. Agreement of physician treatment practices with the international taskforce guidelines for diagnosis and treatment of dry eye disease. Cornea 2007; 26:284-289.